Related Experiment Video
Updated: Jan 20, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Fisetin effects on cell proliferation and apoptosis in glioma cells
Fulya Pak1, Pinar Oztopcu-Vatan2
1Graduated School of Natural and Applied Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.
Abstract:
This research investigated the antiproliferative effects of 1-500 μM fisetin in T98G and BEAS-2B cells by MTT assay. The IC50 of fisetin in T98G cells for 24 and 48 h were 93 and 75 μM, respectively. Apoptotic alterations of fisetin-treated T98G cells were observed by transmission electron microscopy. BEAS-2B was then used in comparison to T98G cells to determine the cytotoxic effects of fisetin. The IC50 of fisetin for 24 and 48 h were recorded as 270 and 90 μM in BEAS-2B cells, respectively. Different concentrations of fisetin were selected to determine the apoptotic and necrotic effects. Consequently, fisetin was determined to have more apoptotic effects in T98G than BEAS-2B cells, dose- and time-dependently. Moreover, fisetin was found to have cytotoxicity at lower doses in T98G cells compared to carmustine, as positive control. CASPASE 3, CASPASE 9, CASPASE 8, and BAX expressions were increased by the selected fisetin doses of 25 and 50 μM, while that of BCL-2 and survivin was reduced in T98G cells. These results will serve as an essential basis of future in vitro and in vivo studies, in the continuous search for alternative treatment agents for gliomas.
Insights
Fisetin exhibits significant antiproliferative and apoptotic effects on T98G glioma cells, showing greater efficacy than carmustine. This natural compound demonstrates potential as an alternative glioma treatment.
Area of Science:
- Pharmacology and Toxicology
- Cell Biology
- Cancer Research
Background:
- Glioblastoma multiforme (GBM) remains a challenging malignancy with limited treatment options.
- Natural compounds are being explored for their potential anticancer properties.
- Fisetin, a flavonoid, has shown promise in preclinical studies, but its specific effects on glioma cells require further elucidation.
Purpose of the Study:
- To investigate the antiproliferative and cytotoxic effects of fisetin on T98G (glioblastoma) and BEAS-2B (normal bronchial epithelial) cells.
- To compare the apoptotic and necrotic effects of fisetin in these cell lines.
- To evaluate the potential of fisetin as an alternative therapeutic agent for gliomas.
Main Methods:
- Cell viability was assessed using the MTT assay to determine the half-maximal inhibitory concentration (IC50) of fisetin.
- Apoptotic alterations in fisetin-treated T98G cells were visualized using transmission electron microscopy.
- Expression levels of apoptosis-related proteins (CASPASE 3, 9, 8, BAX, BCL-2, survivin) were analyzed in T98G cells.
Main Results:
- Fisetin demonstrated dose- and time-dependent antiproliferative effects in both T98G and BEAS-2B cells.
- The IC50 values for fisetin were significantly lower in T98G cells (75-93 μM) compared to BEAS-2B cells (90-270 μM) at 48 hours.
- Fisetin induced apoptosis more effectively in T98G cells than in BEAS-2B cells, with increased expression of pro-apoptotic proteins (CASPASEs, BAX) and decreased expression of anti-apoptotic proteins (BCL-2, survivin).
Conclusions:
- Fisetin exhibits potent dose- and time-dependent antiproliferative and apoptotic effects, particularly in T98G glioma cells.
- Fisetin's cytotoxicity is more pronounced in T98G cells compared to normal BEAS-2B cells, suggesting potential therapeutic selectivity.
- The observed modulation of apoptosis-related gene expression supports fisetin's mechanism of action and warrants further investigation for glioma treatment.
Related Concept Videos
Cells Coordinate Growth and Proliferation
Apoptosis
Abnormal Proliferation
Adult Stem Cells
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Biological Effects of Radiation

